|
|
Volumn 23, Issue 1, 2009, Pages 17-22
|
|
Intravitreal bevacizumab for treatment of diabetic macular edema.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ARTICLE;
COMPARATIVE STUDY;
DIABETIC RETINOPATHY;
DRUG ANTAGONISM;
FEMALE;
FOLLOW UP;
HUMAN;
INJECTION;
LOW LEVEL LASER THERAPY;
MALE;
METHODOLOGY;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOLOGY;
RETINA MACULA EDEMA;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
VISUAL ACUITY;
VITRECTOMY;
VITREOUS BODY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
DIABETIC RETINOPATHY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INJECTIONS;
LASER THERAPY;
MACULAR EDEMA;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITRECTOMY;
VITREOUS BODY;
|
|
EID: 67650218653
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2009.23.1.17 Document Type: Article |
|
Times cited : (20)
|
|
References (0)
|
